Cidara Therapeutics to Present Ongoing Development of
SAN DIEGO, June 20, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics...
Source: globenewswire.com
Page 5 - Veronica Eames News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Veronica Eames. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Veronica Eames Today - Breaking & Trending Today
Cidara Therapeutics to Present Ongoing Development of Drug-Fc Conjugates (DFC) Including CD73-Targeting DFC From Its Cloudbreak® Platform at Adenosine-Pathway Targeted Cancer Immunotherapy Summit
SAN DIEGO, June 20, 2023 -- Cidara Therapeutics, Inc. , a biotechnology company developing long-acting therapeutics designed to help improve the standard of care for patients facing serious... | June 20, 2023
Source: marketscreener.com
Aligos Therapeutics to Present Data on its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023
SOUTH SAN FRANCISCO, Calif., June 07, 2023 -- Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver... | June 7, 2023
Source: marketscreener.com
Araris Biotech AG Supported with CHF 2.5M Swiss Accelerator
Innosuisse supports 53 companies out of 752 applications with total CHF 112MAraris’ awarded grant will be used to support further development and...
Source: globenewswire.com
Cidara Therapeutics Receives $20 Million Milestone Payment Following FDA Approval of REZZAYO™
– U.S. launch of REZZAYO by Melinta expected in mid-2023 –– Company eligible to receive up to an additional $47 million in milestones from multiple existing partnerships based on... | April 24, 2023
Source: marketscreener.com